SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-210677
Filing Date
2023-08-11
Accepted
2023-08-11 16:00:53
Documents
15
Period of Report
2023-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d641513d8k.htm   iXBRL 8-K 25808
2 EX-99.1 d641513dex991.htm EX-99.1 90052
3 EX-99.2 d641513dex992.htm EX-99.2 40107
7 GRAPHIC g641513g0810024401520.jpg GRAPHIC 1224
  Complete submission text file 0001193125-23-210677.txt   299327

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20230807.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20230807_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20230807_pre.xml EX-101.PRE 10823
9 EXTRACTED XBRL INSTANCE DOCUMENT d641513d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 231163861
SIC: 3841 Surgical & Medical Instruments & Apparatus